Bactiguard Holding

Business and Financial Review • Dec 23, 2015

Press release Stockholm, 23 December 2015

Adjusted additional order from Bard

In August 2015, Bactiguard received a one off order from C.R. Bard (Bard), intended to increase their safety stock, which generated additional sales of approximately 28 MSEK in the third quarter. Bard has subsequently revised their need of safety stock. This adjustment will have a negative impact on Bactiguard's revenues of approximately 8 MSEK.

The additional order was intended to increase Bard's safety stock. Following an internal analysis, Bard has now concluded that the safety stock order placed in August was incorrect and that an order worth approximately 20 MSEK would have been sufficient.

Part of the additional order, corresponding to a value of approximately 8 MSEK, will therefore be used in Bard's regular production. This will have a corresponding negative impact on Bactiguard's revenues, primarily in the fourth quarter and early next year.

This is information that Bactiguard Holding AB (publ) is required to publish in compliance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on 23 December 2015, at 08.00

For further information, please contact:

Ulrika Berglund, Head of External Affairs, mobile: +46 708 800 407

About Bactiguard

Bactiguard is a Swedish medtech company with a mission of preventing healthcare associated infections, reducing the use of antibiotics and saving lives by developing and supplying infection prevention solutions for the healthcare industry. The company's patented coating prevents healthcare associated infections by reducing bacterial adhesion and growth on medical devices. Bactiguard®-coated urinary catheters are market leading in the US and Japan, and in recent years the company has developed its own product portfolio of catheters for the urinary and respiratory tract and the blood stream. Bactiguard is currently in a strong expansion phase, focused on new markets in the Europe, Middle East, Asia, Latin America and Southern Africa. The company has market presence in some 50 countries and has about 60 employees. Its headquarters are located in Stockholm and production facilities in Sweden and Malaysia. Bactiguard is listed on Nasdaq Stockholm. Read more about Bactiguard at www.bactiguard.com.